Viewing entries tagged
Stewart & Stewart

Actos Mass Tort Ads Track Litigation Developments

Actos Mass Tort Ads Track Litigation Developments

Mass tort advertising targeting the diabetes drug Actos increased by 65% in September -- following the loss of a bid in August to throw out a $9 billion punitive-damage award over claims the drugmakers, Takeda and Eli Lilly, hid the cancer risks of the diabetes medicine. While the drugmakers subsequently won a more than 99 percent cut in the award in ruling on a separate motion earlier this week, the reduced award total of $36.8 million will likely be subject to further appeal. The increase is consistent with earlier shifts in Actos mass tort advertising following key litigation developments. Read full article.